29th Addendum to Lease Agreement No. 01/2003 between BioCentiv GmbH and 4-Antibody AG

Contract Categories: Real Estate Lease Agreements
Summary

BioCentiv GmbH and 4-Antibody AG have amended their existing lease agreement, effective September 1, 2013. This addendum updates the monthly rent and prepaid incidental expenses for the period from September 2013 through December 2013, and sets new amounts starting January 2014. All other terms of the original lease remain unchanged. The agreement is signed by authorized representatives of both parties.

EX-10.4.3 12 agen-exhibit1043q114.htm AMENDMENT 29 TO COMMERCIAL LEASE AGEN-Exhibit 10.4.3 Q1 14

29th Addendum to the BioCentiv – 4-Antibody Lease Agreement from 08/09/2013

BioCentiv [logo]


29th Addendum
to Lease Agreement No. 01/2003
from 12/01/2002

BioCentiv GmbH        (Lessor)
and             4-Antibody AG        (Lessee)

amend the above-mentioned Lease Agreement per 09/01/2013 as follows:


Section 4 Rent, other payments

(1) b    The prepaid incidental expenses from September to December 2013 are set to €7,959.93.

The prepaid incidental expenses starting January 2014 are set to €6,279.98.


Starting 09/01/2013–12/31/2013, the total monthly rent is as follows:

Subtotal rent, net

€8,891.11

Center’s flat charge, net

€859.20

Prepaid incidental expenses

€7,959.93

Total rent, net

€17,710.24

19% VAT

€3,364.95

Total rent, gross

€21,075.19




Starting 01/01/2014, the total monthly rent is as follows:

Subtotal rent, net

€8,891.11

Center’s flat charge, net

€859.20

Prepaid incidental expenses

€6,279.98

Total rent, net

€16,030.29

19% VAT

€3,045.76

Total rent, gross

€19,076.05













Page 1 of 2

29th Addendum to the BioCentiv – 4-Antibody Lease Agreement from 08/09/2013

BioCentiv [logo]


All other provisions of the Lease Agreement remain in effect.



Jena, 08/09/2013


BioCentiv GmbH
4-Antibody AG
Germany Branch

[signature]
Dr. Klaus Ullrich
Director
[signature]
Dr. Robert Burns
Director
[signature]
Dr. Luis Martin-Parras
Authorized Agent




































Page 2 of 2